Sageworth Trust’s CONMED CNMD Stock Holding History

Sageworth Trust’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-89	Closed	-$9.24K	–	160
2023 Q1	$9.24K	Buy	+89	New	+$8.61K	﹤0.01%	294

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Sageworth Trust's CNMD Position: Q2 2023 in Review

Sageworth Trust sold out of CONMED (CNMD) in Q2 2023, closing a stake of 89 shares — an estimated $9.24K sold.

Sageworth Trust first reported a position in CNMD in Q1 2023 and held it in 1 quarter. The position peaked at $9.24K in Q1 2023. 263 funds tracked by Wall St. Rank hold CNMD as of Q2 2023.

Sageworth Trust reported no remaining CONMED position as of Q2 2023 after selling out during the quarter.
Sageworth Trust sold 89 CONMED shares in Q2 2023, an estimated $9.24K.
Sageworth Trust first reported a position in CONMED in Q1 2023 and held it in 1 quarter.
Sageworth Trust's CONMED position peaked at $9.24K in Q1 2023.
263 funds tracked by Wall St. Rank held CONMED as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.